Trial Profile
Aging White Matter Changes, Executive Dysfunction and Depression.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 04 Apr 2017 Status changed from active, no longer recruiting to completed.
- 23 Jun 2009 New trial record